1. |
Lyon G, Dodge PR, Adams RD. The acute encephalopathies of obscure origin in infants and children. Brain, 1961, 84: 680-708.
|
2. |
Sakuma H, Fukumizu M, Kohyama J. Efficacy of anticonvulsants on acute encephalitis with refractory, repetitive partial seizures (AERRPS). No ToHattatsu, 2001, 33(5): 385-390.
|
3. |
Mikaeloff Y, Jambaqué I, Hertz-Pannier L, et al. Devastating epileptic encephalopathy in school-aged children (DESC): A pseudo encephalitis. Epilepsy Res, 2006, 69(1): 67-79.
|
4. |
van Baalen A, Vezzani A, H usler M, et al. Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics, 2017, 48(1): 5-18.
|
5. |
Ismail FY, Kossoff EH. AERRPS, DESC, NORSE, FIRES: multi-labeling or distinct epileptic entities.Epilepsia, 2011, 52(11): e185-e189.
|
6. |
Sato Y, Numata-Uematsu Y, Uematsu M, et al. Acute encephalitis with refractory, repetitive partial seizures: pathological findings and A new therapeutic approach using tacrolimus. Brain Dev, 2016, 38(8): 772-776.
|
7. |
van Baalen A, H usler M, Plecko-Startinig B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: A case series and discussion of epileptogenesis in FIRES. Neuropediatrics, 2012, 43(4): 209-216.
|
8. |
Kramer U, Chi CS, Lin KL, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: A multicenter study on 77 children. Epilepsia, 2011, 52(11): 1956-1965.
|
9. |
Sutter R, Kaplan PW. Can anesthetic treatment worsen outcome in status epilepticus. Epilepsy Behav, 2015, 49: 294-297.
|
10. |
Bellante F, Legros B, Depondt C, et al. Midazolam and thiopental for the treatment of refractory status epilepticus: A retrospective comparison of efficacy and safety. J Neurol, 2016, 263(4): 799-806.
|
11. |
Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia, 2010, 51(10): 2033-2037.
|
12. |
Singh RK, Joshi SM, Potter DM, et al. Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet. Pediatrics, 2014, 134(5): e1431-e1435.
|
13. |
Chang P, Augustin K, Boddum K, et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain, 2016, 139(Pt 2): 431-443.
|
14. |
Dupuis N, Curatolo N, Benoist JF, et al. Ketogenic diet exhibits anti-inflammatory properties. Epilepsia, 2015, 56(7): e95-e98.
|
15. |
Farias-Moeller R, Bartolini L, Pasupuleti A, et al. A practical approach to ketogenic diet in the pediatric intensive care unit for super-refractory status epilepticus. Neurocrit Care, 2017, 26(2): 267-272.
|
16. |
Baumeister FA, Oberhoffer R, Liebhaber GM, et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics, 2004, 35(4): 250-252.
|
17. |
Gofshteyn JS, Wilfong A, Devinsky O, et al. Cannabidiol as A potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases. J Child Neurol, 2017, 32(1): 35-40.
|